RACHEL CHILDERS: Open Payments
NPI 1730750209 · FLOWER MOUND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,839 in 177 payments from 22 companies in 2025. Trend: 2023 $2,687 · 2024 $2,259 · 2025 $2,839
Food & beverage: $2,839
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 30 | $550 |
| Neurocrine BioSciences, Inc. | 19 | $338 |
| Janssen Pharmaceuticals, Inc | 18 | $275 |
| Otsuka America Pharmaceutical, Inc. | 25 | $274 |
| Lundbeck LLC | 13 | $210 |
| ABBVIE INC. | 18 | $196 |
| Collegium Pharmaceutical, Inc. | 11 | $150 |
| Indivior Inc. | 6 | $116 |
| Noven Therapeutics, LLC | 5 | $105 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $86 |
Products named: REXULTI, INGREZZA, UZEDY, INVEGA SUSTENNA, AUSTEDO XR, VRAYLAR, Jornay PM, ABILIFY ASIMTUFII.
Industry payments across TX — which companies pay providers there.
